<p>CELs = contrast-enhancing lesions (number); LV = lesion volume (mL); NBV = normalized brain volume (mL); NWMV = normalized white matter volume (mL); NGMV = normalized gray matter volume. (mL).</p
Background: In multiple sclerosis (MS), brain atrophy depicted by magnetic resonance imaging reflect...
Volume loss in some limbic region structures has been observed in multiple sclerosis (MS) patients. ...
Changes in the volume of brain gray matter in people with multiple sclerosis (MS) are a core MRI fea...
Multiple sclerosis (MS) is a chronic disease with an inflammatory and neurodegenerative pathology. A...
Multiple sclerosis (MS) is a chronic disease with an inflammatory and neurodegenerative pathology. A...
[[sponsorship]]統計科學研究所[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/Ga...
Background The added value of brain volume measurements in the clinical practice of multiple scleros...
Purpose: Thalamic atrophy and whole brain atrophy in multiple sclerosis (MS) are associated with dis...
Background: Volumetric MRI surrogate markers of disease progression are lacking. Objective: To estab...
<p>Distributions of normalized cortical gray matter (A) and cerebral white matter (B) volumes in hea...
Background: The continuous progress of information technology has made possible the creation of tool...
<p>Purpose: Thalamic atrophy and whole brain atrophy in multiple sclerosis (MS) are associated with ...
BACKGROUND AND PURPOSE: Although the number of enhancing lesions is the typical outcome measure of c...
Brain volumetric measurements in multiple sclerosis (MS) reflect not only disease-specific processes...
Objective—Hemodynamic abnormality and disruption of white matter (WM) integrity are significant comp...
Background: In multiple sclerosis (MS), brain atrophy depicted by magnetic resonance imaging reflect...
Volume loss in some limbic region structures has been observed in multiple sclerosis (MS) patients. ...
Changes in the volume of brain gray matter in people with multiple sclerosis (MS) are a core MRI fea...
Multiple sclerosis (MS) is a chronic disease with an inflammatory and neurodegenerative pathology. A...
Multiple sclerosis (MS) is a chronic disease with an inflammatory and neurodegenerative pathology. A...
[[sponsorship]]統計科學研究所[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/Ga...
Background The added value of brain volume measurements in the clinical practice of multiple scleros...
Purpose: Thalamic atrophy and whole brain atrophy in multiple sclerosis (MS) are associated with dis...
Background: Volumetric MRI surrogate markers of disease progression are lacking. Objective: To estab...
<p>Distributions of normalized cortical gray matter (A) and cerebral white matter (B) volumes in hea...
Background: The continuous progress of information technology has made possible the creation of tool...
<p>Purpose: Thalamic atrophy and whole brain atrophy in multiple sclerosis (MS) are associated with ...
BACKGROUND AND PURPOSE: Although the number of enhancing lesions is the typical outcome measure of c...
Brain volumetric measurements in multiple sclerosis (MS) reflect not only disease-specific processes...
Objective—Hemodynamic abnormality and disruption of white matter (WM) integrity are significant comp...
Background: In multiple sclerosis (MS), brain atrophy depicted by magnetic resonance imaging reflect...
Volume loss in some limbic region structures has been observed in multiple sclerosis (MS) patients. ...
Changes in the volume of brain gray matter in people with multiple sclerosis (MS) are a core MRI fea...